Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenya Tang

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Genes|March 28, 2025
The Heterogeneity of 13q Deletions in Chronic Lymphocytic Leukemia: Diagnostic Challenges and Clinical ImplicationsChangqing Xia, Guang Liu, Jinglan Liu, et al.
Leukemia Research|November 9, 2020
Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangementHaipeng Shao, Wei Wang, Jinming Song, et al.
Annals of Hematology|February 20, 2022
3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplantGuilin Tang, Ying Zou, Sa A Wang, et al.
Cancer Medicine|June 8, 2019
Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?Zhining Chen, Yi Sun, Wei Xie, et al.
Cancers|May 14, 2025
Clinical Utility of Optical Genome Mapping as an Additional Tool in a Standard Cytogenetic Workup in Hematological MalignanciesGokce A Toruner, Shimin Hu, Sanam Loghavi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2020
iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcomeWei Xie, Jie Xu, Shimin Hu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 9, 2016
Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasmsRashmi S Goswami, Sa A Wang, Courtney DiNardo, et al.
American Journal of Hematology|July 7, 2015
Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemiaGuilin Tang, Bing Fu, Shimin Hu, et al.
Cancer Genetics|December 25, 2022
Clinical impact of 5<sup>'</sup>MYC or 3<sup>'</sup>MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomasGuilin Tang, Shaoying Li, Gokce A Toruner, et al.
Genes|November 27, 2024
Optical Genome Mapping for Detection of <i>BCR::ABL1</i>-Another Tool in Our ToolboxZhenya Tang, Wei Wang, Gokce A Toruner, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Genes|March 28, 2025
The Heterogeneity of 13q Deletions in Chronic Lymphocytic Leukemia: Diagnostic Challenges and Clinical ImplicationsChangqing Xia, Guang Liu, Jinglan Liu, et al.
Leukemia Research|November 9, 2020
Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangementHaipeng Shao, Wei Wang, Jinming Song, et al.
Annals of Hematology|February 20, 2022
3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplantGuilin Tang, Ying Zou, Sa A Wang, et al.
Cancer Medicine|June 8, 2019
Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?Zhining Chen, Yi Sun, Wei Xie, et al.
Cancers|May 14, 2025
Clinical Utility of Optical Genome Mapping as an Additional Tool in a Standard Cytogenetic Workup in Hematological MalignanciesGokce A Toruner, Shimin Hu, Sanam Loghavi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2020
iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcomeWei Xie, Jie Xu, Shimin Hu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 9, 2016
Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasmsRashmi S Goswami, Sa A Wang, Courtney DiNardo, et al.
American Journal of Hematology|July 7, 2015
Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemiaGuilin Tang, Bing Fu, Shimin Hu, et al.
Cancer Genetics|December 25, 2022
Clinical impact of 5<sup>'</sup>MYC or 3<sup>'</sup>MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomasGuilin Tang, Shaoying Li, Gokce A Toruner, et al.
Genes|November 27, 2024
Optical Genome Mapping for Detection of <i>BCR::ABL1</i>-Another Tool in Our ToolboxZhenya Tang, Wei Wang, Gokce A Toruner, et al.
Pageof 14